Loading clinical trials...
Loading clinical trials...
Once a Day Immunosuppression Regimen: Outcomes and Compliance
The purpose of this research study is to determine whether an immunosuppressive maintenance regimen of Envarsus/azathioprine compared to a tacrolimus/ mycophenolic acid regimen is associated with better compliance, tolerability, and lower biopsy proven rejection.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Washington University
St Louis, Missouri, United States
Start Date
June 4, 2018
Primary Completion Date
November 10, 2023
Completion Date
November 10, 2023
Last Updated
January 22, 2025
51
ACTUAL participants
Once daily immunosuppression regimen
DRUG
Twice daily immunosuppression regimen
DRUG
Lead Sponsor
Washington University School of Medicine
Collaborators
NCT06958796
NCT04702022
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions